A model for evaluating topical antimicrobial efficacy against methicillin-resistant Staphylococcus aureus biofilms in superficial murine wounds

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 8, 2012, Pages 4508-4510

  Roche, Eric D ^a   Renick, Paul J ^a,b   Tetens, Shannon P ^a   Carson, Dennis L ^a  

^a Healthpoint Biotherapeutics   (United States)

^b UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AQUACEL AG; BACITRACIN ZINC; PSEUDOMONIC ACID; SILVER; SULFADIAZINE SILVER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOFILM; CREAM; DRUG EFFICACY; DRUG IDENTIFICATION; DRUG SCREENING; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOUSE; NONHUMAN; OINTMENT; PRIORITY JOURNAL; TREATMENT OUTCOME; WOUND INFECTION;

ADMINISTRATION, TOPICAL; ANIMALS; ANTI-INFECTIVE AGENTS, LOCAL; BACITRACIN; BIOFILMS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICE; MUPIROCIN; SILVER COMPOUNDS; SILVER SULFADIAZINE; WOUND INFECTION;

EID: 84864386146     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00467-12     Document Type: Article

References (11)

1. Agostinho AM, et al. 2011. An in vitro model for the growth and analysis of chronic wound MRSA biofilms. J. Appl. Microbiol. 111:1275-1282.
2. Gurjala AN, et al. 2011. Development of a novel, highly quantitative in vivo model for the study of biofilm-impaired cutaneous wound healing. Wound Repair Regen. 19:400-410.
3. Hurdle JG, Yendapally R, Sun D, Lee RE. 2009. Evaluation of analogs of reutericyclin as prospective candidates for treatment of staphylococcal skin infections. Antimicrob. Agents Chemother. 53:4028-4031.
4. James GA, et al. 2008. Biofilms in chronic wounds. Wound Repair Regen. 16:37-44.
5. Kirketerp-Møller K, et al. 2008. The distribution, organization, and ecology of bacteria in chronic wounds. J. Clin. Microbiol. 46:2717-2722.
6. Kugelberg E, et al. 2005. Establishment of a superficial skin infection model in mice by using Staphylococcus aureus and Streptococcus pyogenes. Antimicrob. Agents Chemother. 49:3435-3441. (Pubitemid 41060593)
7. Percival SL, Hill KE, Malic S, Thomas DW, Williams DW. 2011. Antimicrobial tolerance and the significance of persister cells in recalcitrant chronic wound biofilms. Wound Repair Regen. 19:1-9.
8. Schierle CF, De la Garza M, Mustoe TA, Galiano RD. 2009. Staphylococcal biofilms impair wound healing by delaying reepithelialization in a murine cutaneous wound model. Wound Repair Regen. 17:354-359.
9. Seth AK, et al. 2012. Treatment of Pseudomonas aeruginosa biofilm-infected wounds with clinical wound care strategies: a quantitative study using an in vivo rabbit ear model. Plast. Resconstr. Surg. 129:262e-274e.
10. Zhao G, et al. 2010. Delayed wound healing in diabetic (db/db) mice with Pseudomonas aeruginosa biofilm challenge: a model for the study of chronic wounds. Wound Repair Regen. 18:467-477.
11. Zuluaga AF, et al. 2006. Neutropenia induced in outbred mice by a simplified low-dose cyclophosphamide regimen: characterization and applicability to diverse experimental models of infectious diseases. BMC Infect. Dis. 6:55.